ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

2025-01-27 – Press Releases – www.prnewswire.com

TOKYO, Jan. 28, 2025 /PRNewswire/ — ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyte. The announcement…

Read the full article here.